Last update Oct. 4, 2020
Incompatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Congenital lactose intolerance belongs to this group or family:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
A very rare and extremely serious disease, via autosomal recessive inheritance (Vandenplas 2015, Diekmann 2015, Torniainen 2009, Järvelä 1998, Levin 1970).
The congenital absence of intestinal lactase prevents the hydrolyzing of lactose in breastmilk, resulting in very serious diarrhea from the first days of life (Torniainen 2009, Savilahti 1973, Levin 1970).
Although the treatment consists of a lactose-free diet and, therefore, it is not possible to breastfeed, there is a reported case of feeding an infant suffering from congenital lactose intolerance with hydrolyzed bank milk with added lactase: 900 units of lactase activity in 200 ml of milk (Similä 1982).
Breastfeeding is not contraindicated in temporary intolerance secondary to gastroenteritis (Vandenplas 2015).